You are here: Home » News-CM » Companies » Results
Business Standard

ERIS Lifesciences consolidated net profit rises 8.66% in the September 2019 quarter

Capital Market 

Sales rise 7.64% to Rs 280.46 crore

Net profit of ERIS Lifesciences rose 8.66% to Rs 92.71 crore in the quarter ended September 2019 as against Rs 85.32 crore during the previous quarter ended September 2018. Sales rose 7.64% to Rs 280.46 crore in the quarter ended September 2019 as against Rs 260.56 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales280.46260.56 8 OPM %39.1738.64 -PBDT114.50100.59 14 PBT102.7792.31 11 NP92.7185.32 9

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, November 08 2019. 11:22 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU